Alpine Global Management, LLC Neurocrine Biosciences Inc Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $562,574 - $736,199	-7,765 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $618,482 - $824,798	7,765 New	7,765 $661,000
Q1 2020 Apr 09, 2020	SELL	$75.11 - $113.76 $243,055 - $368,127	-3,236 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$86.8 - $118.57 $280,884 - $383,692	3,236 New	3,236 $348,000
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $178,930 - $325,698	-2,619 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$98.88 - $125.85 $258,966 - $329,601	2,619 New	2,619 $322,000

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.